Dr Gregory Boren, MD | |
3131 Queen City Ave, Cincinnati, OH 45238-2316 | |
(513) 389-5268 | |
Not Available |
Full Name | Dr Gregory Boren |
---|---|
Gender | Male |
Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
Location | 3131 Queen City Ave, Cincinnati, Ohio |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1770558322 | NPI | - | NPPES |
0532123 | Medicaid | OH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 35031085 (Ohio) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Gregory Boren, MD 5620 Southwyck Blvd, Toledo, OH 43614-1501 Ph: (419) 866-1804 | Dr Gregory Boren, MD 3131 Queen City Ave, Cincinnati, OH 45238-2316 Ph: (513) 389-5268 |
News Archive
Today, five Florida nonprofits were honored for their dedication to improving the health of the state's uninsured and underserved populations at the Sapphire Award ceremony, presented annually by the Blue Cross and Blue Shield of Florida Foundation (BCBSF Foundation).
A study led by investigators at Beth Israel Deaconess Medical Center (BIDMC) has demonstrated that a new immunohistochemical test is reliable in diagnosing a dangerous arrhythmic heart disease known as arrhythmogenic right ventricular cardiomyopathy (ARVC.) Reported in the March 12 issue of The New England Journal of Medicine ( NEJM ), the new findings offer the possibility of a highly sensitive and specific means of identifying this life- threatening condition at an early stage, when it can be treated with by implanting a cardiac defibrillator.
A diagnostic test based on chromosomal rearrangements can trace the lineage of lung cancer to determine whether two separate lung cancers in the same patient are independent tumors or a tumor that has spread to another region of the lung, a Mayo Clinic study has found. For patients with multiple tumors, that distinction could mean the difference between early stage cancer that may be cured by surgery and incurable late-stage disease.
Today's headlines include a number of reports regarding a new proposed rule by the Department of Health and Human Services that will require insurers to justify large premium hikes.
BrainsWay Ltd., the parent company of BrainsWay USA, Inc., and a global leader in the advanced non-invasive treatment of brain disorders, today announces that it has received De Novo clearance from the U.S. Food and Drug Administration (FDA) for its deep transcranial magnetic stimulation (Deep TMS) system for the treatment of obsessive-compulsive disorder (OCD) in adults.
› Verified 9 days ago
Bruce G Storrs, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 375 Dixmyth Ave, Cincinnati, OH 45220 Phone: 513-872-1400 | |
Mei Liang, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 234 Goodman St, Lab Medicine Building, Cincinnati, OH 45219 Phone: 513-584-3834 Fax: 513-558-2289 | |
Parsa Hodjat, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 3333 Burnet Ave., Ml 1035, Cincinnati, OH 45229 Phone: 513-636-4261 Fax: 513-636-3924 | |
Gregory Retzinger, MD Pathology Medicare: Medicare Enrolled Practice Location: 231 Albert Sabin Way, Department Of Pathology, Cincinnati, OH 45267 Phone: 513-558-4500 Fax: 513-558-2289 | |
Ila N Mehta Iii, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 375 Dixmyth Ave, Cincinnati, OH 45220 Phone: 513-624-4337 | |
Jiang Wang, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 234 Goodman St, Cincinnati, OH 45219 Phone: 513-584-1000 Fax: 513-584-3778 | |
Dani S Zander, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 234 Goodman St, Cincinnati, OH 45219 Phone: 513-584-7284 Fax: 513-584-3807 |